心血管

订阅

MedSci主页 / 所有栏目 / 心血管

JAHA：冠脉搭桥术后6-12h的cTnT水平能预测患者预后

2018-02-28 MedSci MedSci原创

心血管冠心病cTnT
关注

心肌肌钙蛋白T（cTnT）水平会在冠脉搭桥术后常规检测。本研究的目的旨在评估cTnT水平与冠脉搭桥术后6-12小时预后的关系。本研究纳入了1722名接受孤立性冠脉搭桥术的患者，评估了749名患者的传统cTnT水平和973名患者的高敏cTnT（hs-cTnT）水平与术后6-12小时主要心脑血管不良事件（MACCE）的发生的相关性。在传统cTnT评估组，有92名（12%）患者出现了MACCE，在hs-

心肌肌钙蛋白T（cTnT）水平会在冠脉搭桥术后常规检测。本研究的目的旨在评估cTnT水平与冠脉搭桥术后6-12小时预后的关系。本研究纳入了1722名接受孤立性冠脉搭桥术的患者，评估了749名患者的传统cTnT水平和973名患者的高敏cTnT（hs-cTnT）水平与术后6-12小时主要心脑血管不良事件（MACCE）的发生的相关性。在传统cTnT评估组，有92名（12%）患者出现了MACCE，在hs-cTnT评估组，有114名（12%）患者出现了MACCE。与cTnT ≤200 ng/L的患者相比，cTnT每增加200 ng/L，患者的MACCE的发生率更高，传统cTnT和hs-cTnT均能较好地区分出MACCE患者。以800 ng/L作为分界点，传统cTnT和hs-cTnT能为临床MACCE提供有效的支持力。研究结果显示，冠脉搭桥术后6-12h的心肌肌钙蛋白T水平可以提示患者的主要心脑血管不良事件发生的风险。原始出处：Brigitta G et al.Prognostic Value of Early Postoperative Troponin T in Patients Underg

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1689323, encodeId=ee9a16893238e, content=<a href='/topic/show?id=adfb5421c9' target=_blank style='color:#2F92EE;'>#cTnT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5421, encryptionId=adfb5421c9, topicName=cTnT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f528789877, createdName=ms1467340776200723, createdTime=Thu Aug 02 19:11:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691963, encodeId=115f169196374, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Wed Sep 12 14:11:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682077, encodeId=9b0016820e777, content=<a href='/topic/show?id=202b309688b' target=_blank style='color:#2F92EE;'>#冠脉搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30968, encryptionId=202b309688b, topicName=冠脉搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d41e27933971, createdName=ZGMFX33A, createdTime=Wed Sep 19 05:11:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663920, encodeId=901e16639204f, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Thu Sep 27 22:11:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267745, encodeId=223f126e74599, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492367, encodeId=b907149236e30, content=<a href='/topic/show?id=a251569194f' target=_blank style='color:#2F92EE;'>#搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56919, encryptionId=a251569194f, topicName=搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32a28924986, createdName=zzc2214, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552910, encodeId=3f9a155291017, content=<a href='/topic/show?id=696730966a0' target=_blank style='color:#2F92EE;'>#冠脉搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30966, encryptionId=696730966a0, topicName=冠脉搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=710114309336, createdName=yese, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291698, encodeId=14a129169895, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Wed Feb 28 12:37:43 CST 2018, time=2018-02-28, status=1, ipAttribution=)]
    2018-08-02 ms1467340776200723

    #cTnT#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1689323, encodeId=ee9a16893238e, content=<a href='/topic/show?id=adfb5421c9' target=_blank style='color:#2F92EE;'>#cTnT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5421, encryptionId=adfb5421c9, topicName=cTnT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f528789877, createdName=ms1467340776200723, createdTime=Thu Aug 02 19:11:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691963, encodeId=115f169196374, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Wed Sep 12 14:11:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682077, encodeId=9b0016820e777, content=<a href='/topic/show?id=202b309688b' target=_blank style='color:#2F92EE;'>#冠脉搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30968, encryptionId=202b309688b, topicName=冠脉搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d41e27933971, createdName=ZGMFX33A, createdTime=Wed Sep 19 05:11:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663920, encodeId=901e16639204f, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Thu Sep 27 22:11:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267745, encodeId=223f126e74599, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492367, encodeId=b907149236e30, content=<a href='/topic/show?id=a251569194f' target=_blank style='color:#2F92EE;'>#搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56919, encryptionId=a251569194f, topicName=搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32a28924986, createdName=zzc2214, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552910, encodeId=3f9a155291017, content=<a href='/topic/show?id=696730966a0' target=_blank style='color:#2F92EE;'>#冠脉搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30966, encryptionId=696730966a0, topicName=冠脉搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=710114309336, createdName=yese, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291698, encodeId=14a129169895, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Wed Feb 28 12:37:43 CST 2018, time=2018-02-28, status=1, ipAttribution=)]
    2018-09-12 bnurmamat

    #患者预后#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1689323, encodeId=ee9a16893238e, content=<a href='/topic/show?id=adfb5421c9' target=_blank style='color:#2F92EE;'>#cTnT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5421, encryptionId=adfb5421c9, topicName=cTnT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f528789877, createdName=ms1467340776200723, createdTime=Thu Aug 02 19:11:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691963, encodeId=115f169196374, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Wed Sep 12 14:11:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682077, encodeId=9b0016820e777, content=<a href='/topic/show?id=202b309688b' target=_blank style='color:#2F92EE;'>#冠脉搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30968, encryptionId=202b309688b, topicName=冠脉搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d41e27933971, createdName=ZGMFX33A, createdTime=Wed Sep 19 05:11:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663920, encodeId=901e16639204f, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Thu Sep 27 22:11:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267745, encodeId=223f126e74599, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492367, encodeId=b907149236e30, content=<a href='/topic/show?id=a251569194f' target=_blank style='color:#2F92EE;'>#搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56919, encryptionId=a251569194f, topicName=搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32a28924986, createdName=zzc2214, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552910, encodeId=3f9a155291017, content=<a href='/topic/show?id=696730966a0' target=_blank style='color:#2F92EE;'>#冠脉搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30966, encryptionId=696730966a0, topicName=冠脉搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=710114309336, createdName=yese, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291698, encodeId=14a129169895, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Wed Feb 28 12:37:43 CST 2018, time=2018-02-28, status=1, ipAttribution=)]
    2018-09-19 ZGMFX33A

    #冠脉搭桥术#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1689323, encodeId=ee9a16893238e, content=<a href='/topic/show?id=adfb5421c9' target=_blank style='color:#2F92EE;'>#cTnT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5421, encryptionId=adfb5421c9, topicName=cTnT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f528789877, createdName=ms1467340776200723, createdTime=Thu Aug 02 19:11:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691963, encodeId=115f169196374, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Wed Sep 12 14:11:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682077, encodeId=9b0016820e777, content=<a href='/topic/show?id=202b309688b' target=_blank style='color:#2F92EE;'>#冠脉搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30968, encryptionId=202b309688b, topicName=冠脉搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d41e27933971, createdName=ZGMFX33A, createdTime=Wed Sep 19 05:11:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663920, encodeId=901e16639204f, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Thu Sep 27 22:11:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267745, encodeId=223f126e74599, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492367, encodeId=b907149236e30, content=<a href='/topic/show?id=a251569194f' target=_blank style='color:#2F92EE;'>#搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56919, encryptionId=a251569194f, topicName=搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32a28924986, createdName=zzc2214, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552910, encodeId=3f9a155291017, content=<a href='/topic/show?id=696730966a0' target=_blank style='color:#2F92EE;'>#冠脉搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30966, encryptionId=696730966a0, topicName=冠脉搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=710114309336, createdName=yese, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291698, encodeId=14a129169895, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Wed Feb 28 12:37:43 CST 2018, time=2018-02-28, status=1, ipAttribution=)]
    2018-09-27 12498b3em16(暂无昵称)

    #搭桥#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1689323, encodeId=ee9a16893238e, content=<a href='/topic/show?id=adfb5421c9' target=_blank style='color:#2F92EE;'>#cTnT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5421, encryptionId=adfb5421c9, topicName=cTnT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f528789877, createdName=ms1467340776200723, createdTime=Thu Aug 02 19:11:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691963, encodeId=115f169196374, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Wed Sep 12 14:11:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682077, encodeId=9b0016820e777, content=<a href='/topic/show?id=202b309688b' target=_blank style='color:#2F92EE;'>#冠脉搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30968, encryptionId=202b309688b, topicName=冠脉搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d41e27933971, createdName=ZGMFX33A, createdTime=Wed Sep 19 05:11:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663920, encodeId=901e16639204f, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Thu Sep 27 22:11:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267745, encodeId=223f126e74599, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492367, encodeId=b907149236e30, content=<a href='/topic/show?id=a251569194f' target=_blank style='color:#2F92EE;'>#搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56919, encryptionId=a251569194f, topicName=搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32a28924986, createdName=zzc2214, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552910, encodeId=3f9a155291017, content=<a href='/topic/show?id=696730966a0' target=_blank style='color:#2F92EE;'>#冠脉搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30966, encryptionId=696730966a0, topicName=冠脉搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=710114309336, createdName=yese, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291698, encodeId=14a129169895, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Wed Feb 28 12:37:43 CST 2018, time=2018-02-28, status=1, ipAttribution=)]
    2018-03-02 zhaohui6731

    #AHA#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1689323, encodeId=ee9a16893238e, content=<a href='/topic/show?id=adfb5421c9' target=_blank style='color:#2F92EE;'>#cTnT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5421, encryptionId=adfb5421c9, topicName=cTnT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f528789877, createdName=ms1467340776200723, createdTime=Thu Aug 02 19:11:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691963, encodeId=115f169196374, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Wed Sep 12 14:11:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682077, encodeId=9b0016820e777, content=<a href='/topic/show?id=202b309688b' target=_blank style='color:#2F92EE;'>#冠脉搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30968, encryptionId=202b309688b, topicName=冠脉搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d41e27933971, createdName=ZGMFX33A, createdTime=Wed Sep 19 05:11:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663920, encodeId=901e16639204f, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Thu Sep 27 22:11:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267745, encodeId=223f126e74599, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492367, encodeId=b907149236e30, content=<a href='/topic/show?id=a251569194f' target=_blank style='color:#2F92EE;'>#搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56919, encryptionId=a251569194f, topicName=搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32a28924986, createdName=zzc2214, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552910, encodeId=3f9a155291017, content=<a href='/topic/show?id=696730966a0' target=_blank style='color:#2F92EE;'>#冠脉搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30966, encryptionId=696730966a0, topicName=冠脉搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=710114309336, createdName=yese, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291698, encodeId=14a129169895, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Wed Feb 28 12:37:43 CST 2018, time=2018-02-28, status=1, ipAttribution=)]
    2018-03-02 zzc2214

    #搭桥术#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1689323, encodeId=ee9a16893238e, content=<a href='/topic/show?id=adfb5421c9' target=_blank style='color:#2F92EE;'>#cTnT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5421, encryptionId=adfb5421c9, topicName=cTnT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f528789877, createdName=ms1467340776200723, createdTime=Thu Aug 02 19:11:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691963, encodeId=115f169196374, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Wed Sep 12 14:11:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682077, encodeId=9b0016820e777, content=<a href='/topic/show?id=202b309688b' target=_blank style='color:#2F92EE;'>#冠脉搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30968, encryptionId=202b309688b, topicName=冠脉搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d41e27933971, createdName=ZGMFX33A, createdTime=Wed Sep 19 05:11:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663920, encodeId=901e16639204f, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Thu Sep 27 22:11:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267745, encodeId=223f126e74599, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492367, encodeId=b907149236e30, content=<a href='/topic/show?id=a251569194f' target=_blank style='color:#2F92EE;'>#搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56919, encryptionId=a251569194f, topicName=搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32a28924986, createdName=zzc2214, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552910, encodeId=3f9a155291017, content=<a href='/topic/show?id=696730966a0' target=_blank style='color:#2F92EE;'>#冠脉搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30966, encryptionId=696730966a0, topicName=冠脉搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=710114309336, createdName=yese, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291698, encodeId=14a129169895, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Wed Feb 28 12:37:43 CST 2018, time=2018-02-28, status=1, ipAttribution=)]
    2018-03-02 yese

    #冠脉搭桥#

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1689323, encodeId=ee9a16893238e, content=<a href='/topic/show?id=adfb5421c9' target=_blank style='color:#2F92EE;'>#cTnT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5421, encryptionId=adfb5421c9, topicName=cTnT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23f528789877, createdName=ms1467340776200723, createdTime=Thu Aug 02 19:11:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691963, encodeId=115f169196374, content=<a href='/topic/show?id=a450530853c' target=_blank style='color:#2F92EE;'>#患者预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53085, encryptionId=a450530853c, topicName=患者预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f4729287700, createdName=bnurmamat, createdTime=Wed Sep 12 14:11:00 CST 2018, time=2018-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682077, encodeId=9b0016820e777, content=<a href='/topic/show?id=202b309688b' target=_blank style='color:#2F92EE;'>#冠脉搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30968, encryptionId=202b309688b, topicName=冠脉搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d41e27933971, createdName=ZGMFX33A, createdTime=Wed Sep 19 05:11:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663920, encodeId=901e16639204f, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Thu Sep 27 22:11:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267745, encodeId=223f126e74599, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492367, encodeId=b907149236e30, content=<a href='/topic/show?id=a251569194f' target=_blank style='color:#2F92EE;'>#搭桥术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56919, encryptionId=a251569194f, topicName=搭桥术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32a28924986, createdName=zzc2214, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552910, encodeId=3f9a155291017, content=<a href='/topic/show?id=696730966a0' target=_blank style='color:#2F92EE;'>#冠脉搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30966, encryptionId=696730966a0, topicName=冠脉搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=710114309336, createdName=yese, createdTime=Fri Mar 02 01:11:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291698, encodeId=14a129169895, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/22/005b55a98a8b2e8ec8bd5577813de704.jpg, createdBy=29fc2176768, createdName=祝您健康, createdTime=Wed Feb 28 12:37:43 CST 2018, time=2018-02-28, status=1, ipAttribution=)]
    2018-02-28 祝您健康

    学习学习

    0

相关资讯

Heart：二叶主动脉瓣患者的冠脉解剖更多元化

在二叶主动脉瓣（BAV）患者中，冠脉的解剖往往变异较大。本研究的目的旨在评估BAV伴复杂先天性心脏病（CHD）患者的冠脉表型。本研究对84例死于BAV伴复杂CHD的患者进行尸检，对其冠脉的开口和位置进行检查，并与BAV的形态进行关联。结果发现，有23%的患者有高位右冠脉（RCA），有37%的患者有高位左冠脉（LCA），尤其在左心发育不良和流出道畸形患者中最为常见。在左心发育不良患者中，高位LCA（

JACC：行Fontan手术存活至成年的患者预后如何？

对于存活至16岁及以上的接受Fontan手术患者的临床预后尚未阐明。本研究的目的旨在评估接受Fontan手术治疗的成年患者的临床预后。本研究纳入了澳大利亚和新西兰Fontan注册数据库（ANZFR）中年龄≥16岁的患者。最终共纳入分析了683名成年幸存者，有201名患者存在心房肺动脉（AP）交通，482名患者存在全腔静脉肺动脉交通。对于这些患者，30岁的存活率为90%（95% CI： 87%-93

Heart：半乳凝素-3可预测先心病患者的心血管不良事件风险

半乳凝素-3是心衰患者危险分层的生物标志物，本研究的目的旨在评估半乳凝素-3与成年先心病（ACHD）患者发生心血管疾病风险的相关性。本研究纳入了2011年-2013年602名ACHD患者，并对其血浆半乳凝素-3水平进行了检测，主要终点事件是全因死亡率、心衰、住院率、心律失常、血栓栓塞事件和心脏介入治疗。最终，共检测了591名（98%）患者的半乳凝素-3水平，平均年龄33岁，男性占58%，纽约心功能

JACC：体外循环冠脉搭桥术远期生存率要高于非体外循环

我们在比较体外循环和非体外循坏冠状动脉旁路移植术（CABG）的临床效果时，常常忽视了两者远期疗效的差异，目前尚缺乏两者术后5年的疗效差异。本研究的目的旨在对体外循坏和非体外循环CABG的远期效果做一个荟萃分析。本研究对患者术后的死亡率、心梗发生率、心绞痛发生率、卒中发生率和血运重建进行了全面的评估。最终共纳入分析了来自6个临床研究的8145名患者，死亡率在体外循环组是12.3%，在非体外循环组是1

JACC：丙磺舒在治疗高龄痛风患者中心血管发生风险更小

痛风患者发生心血管疾病的风险大大增高。本研究的目的旨在比较评估痛风患者接受的两者不同药物治疗（丙磺舒和别嘌呤醇）在心血管方面的安全性。本研究纳入了2008年至2013年年龄≥65岁服用丙磺舒或别嘌呤醇治疗的痛风患者，主要终点事件是心梗和卒中的复合住院治疗，次要终点事件是心梗、卒中、冠脉血运重建、心衰和死亡。最终，共纳入分析了9722名接受丙磺舒治疗的患者，29166名接受别嘌呤醇治疗的患者，平均年

JACC：心脏磁共振在非梗阻性冠心病心绞痛患者中的诊断价值

在非梗阻性冠心病（NOCAD）心绞痛患者中，确定冠脉微血管功能不良（CMD）至关重要，且难度较高。心脏磁共振（CMR）可以较准确地评估心肌的灌注状态，并被广泛应用于诊断梗阻性冠心病。本研究的目的旨在评估CMR在NOCAD心绞痛患者中的诊断价值。本研究纳入了50名心绞痛患者（65 ± 9岁）和20名年龄匹配的正常对照，对其进行腺苷负荷心脏磁共振检查，以评估左室功能、诱导性心肌缺血和梗塞情况。在接下来